Document Detail


Pharmacokinetic Considerations of Perinatal Antiretroviral Therapy.
MedLine Citation:
PMID:  22452457     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Antiretroviral therapy (ART) in pregnant women represents a unique combination of therapy and prophylaxis of HIV infection. Until the global epidemic of HIV and the discovery of efficient prevention of perinatal transmission through ART, the world has not witnessed a pharmacologic intervention of such a scale during pregnancy and delivery. The use of ART in pregnancy creates unique challenges in delivering therapeutic agents, targeting the HIV virus in both the pregnant woman and her unborn child, throughout dramatic changes in their physiologic state. With an increased complexity of perinatal ART and the introduction of novel agents into clinical practice, a better understanding of the pharmacokinetics (PK) and pharmacodynamics of ARV drugs is crucial for the safe and most effective use of ARV drugs in women during pregnancy and infants in the first months of life. While PK studies are already difficult to perform during pregnancy, they are particularly challenging in women with HIV infection due to multiple social, economic and cultural constrains. In this paper we provide an overview of published studies of ART disposition during pregnancy, labor, breastfeeding and in the newborn infant after delivery.
Authors:
Natella Y Rakhmanina; Sahera Dirajlal-Fargo; Edmund V Capparelli; Mark Mirochnik
Related Documents :
21964517 - Contribution of cryopreservation in a mandatory set policy: analysis of 5 years of appl...
22039027 - Outcomes of fetuses with umbilical cord cysts diagnosed during nuchal translucency exam...
21782017 - Transfer of repaglinide in the dually perfused human placenta and the role of organic a...
21664667 - Does storage time in ln2 influence survival and pregnancy outcome of vitrified rabbit e...
16787717 - Dose dependent effect of gnrh analogue on pregnancy rate of repeat breeder crossbred cows.
3675437 - Pregnancy outcome in women with reflux nephropathy--a review of experience at the royal...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-3-22
Journal Detail:
Title:  Current drug metabolism     Volume:  -     ISSN:  1875-5453     ISO Abbreviation:  -     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-3-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100960533     Medline TA:  Curr Drug Metab     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
The George Washington, University School of Medicine and Health Sciences, Special Immunology Program, Children's National Medical Center, 111 Michigan Avenue, NW,Washington, DC 20010. nrakhman@cnmc.org.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Growing up with midazolam in the neonatal and pediatric intensive care.
Next Document:  Pharmacogenetics of opioids for the treatment of acute maternal pain during pregnancy and lactation.